JWH-018 elevated brain endocannabinoid levels by suppressing their breakdown enzymes and reduced BDNF, a protein critical for learning and memory, with both effects reversible by a CB1 blocker.
Toxicologists, neuroscientists, and harm reduction workers dealing with synthetic cannabinoid use.
Double hit on endocannabinoid system
What the researchers found
JWH-018 elevated anandamide and 2-AG levels in the hippocampus by suppressing the enzymes that break them down (FAAH and MAGL). It simultaneously reduced BDNF, a key protein for synaptic plasticity. All effects were blocked by the CB1 antagonist AM251, confirming CB1-dependent mechanisms.
Why it matters
Synthetic cannabinoids are often far more potent than natural cannabis. Understanding how they impair memory at the molecular level helps explain their cognitive dangers and may inform treatment strategies.
The numbers in context
JWH-018 significantly elevated both AEA and 2-AG levels. FAAH and MAGL activity were suppressed. BDNF levels decreased. All changes were reversed by CB1 antagonist AM251.
How the study worked
Acute JWH-018 administration in rats with hippocampal metabolomic profiling. Endocannabinoid levels, degradation enzyme activity, and BDNF levels measured with and without CB1 antagonist co-administration.
What this study cannot tell us
Acute single-dose study in rats. Chronic exposure effects not examined. Hippocampal metabolomics provides a snapshot, not a dynamic picture. JWH-018 is an older synthetic cannabinoid; newer variants may act differently.
How to read the evidence
Preliminary: single acute-dose rat study.
When this study was published
Published in 2019.
The bigger picture
This study reveals a cascade effect: a synthetic cannabinoid does not just activate CB1 directly but also raises the brain's own cannabinoid levels by blocking their degradation, creating a double hit on the endocannabinoid system that may explain the outsized cognitive impairment seen with synthetic cannabinoids.
Questions still open
- Do newer, more potent synthetic cannabinoids produce even greater endocannabinoid elevation? Could targeting the degradation enzyme pathway mitigate synthetic cannabinoid cognitive damage?
Common questions
Why are synthetic cannabinoids worse for memory than natural cannabis?
What is BDNF and why does it matter?
Read the original research
Elevation of endocannabinoids in the brain by synthetic cannabinoid JWH-018: mechanism and effect on learning and memory.
Scientific reports, 9(1), 9621
Citation
Li, Ren-Shi; Fukumori, Ryo; Takeda, Tomoki; Song, Yingxia; Morimoto, Satoshi; Kikura-Hanajiri, Ruri; Yamaguchi, Taku; Watanabe, Kazuhito; Aritake, Kousuke; Tanaka, Yoshitaka; Yamada, Hideyuki; Yamamoto, Tsuneyuki; Ishii, Yuji. (2019). Elevation of endocannabinoids in the brain by synthetic cannabinoid JWH-018: mechanism and effect on learning and memory.. Scientific reports, 9(1), 9621. https://doi.org/10.1038/s41598-019-45969-4
Explore the wider topic
- THC Purity and Potency: What the Label Actually Means
- Dab and Concentrate Withdrawal: Why It Hits Harder
- Delta-8 THC: Addiction, Withdrawal, and What We Don't Know
- Edible Addiction and Withdrawal: What Makes It Different
- Edibles and Psychosis: When a Bad Trip Becomes an Emergency
- Vaping vs Smoking vs Edibles: A Harm Reduction Guide
- How Cannabis Products Are Made: From Plant to Concentrate to Edible
- Laced Weed and Contaminated Vapes: Real Risks vs Myths
- Legal vs Street Weed: Quality, Safety, and What You're Actually Smoking
- Quitting Weed Pens and Dabs: Why Concentrates Hit Different
- Quitting Edibles: Is Withdrawal Different from Smoking?
- Sativa vs Indica: The Myth and the Science Behind Cannabis Strain Labels
- Why Is Weed Withdrawal Worse Now Than 20 Years Ago?